Purac announces the investment in a new manufacturing facility for its biomedical polymers. The plant is meant to support the growing resorbable polymers business of Purac Biomaterials. Purac currently operates a plant for biomedical polymers in The Netherlands. This second facility will be built in the USA. The investment for this new plant will be EUR 15 million. The construction of the facility will start in 2011 and is expected to be completed before the end of the year.
Arno van de Ven, Purac Vice President Chemicals & Pharma comments: "This represents an important step in the biomedical polymer business and shows Purac’s continued commitment to this market. It provides us with the capability to support the growth of our existing and new business partners.” Besides an increase in the production capacity, the new facility will bring Purac Biomaterials more flexibility and a more balanced presence in its global markets.